MAPT and Parkinson disease: Hall et al. demonstrated through proteomic analysis that the Tau phosphorylation patterns (such as p-tau231) in PD-MCI patients differ from those in AD-MCI and may contribute to synaptic toxicity formation together with α-synuclein (32).